These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33571371)
41. [Application of immunohistochemistry for p16 and GATA3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma]. Huang RF; He C; Zhu WF; Li Y; Chen G Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):388-392. PubMed ID: 28591985 [No Abstract] [Full Text] [Related]
42. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions. Lew M; Pang JC; Jing X; Fields KL; Roh MH Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236 [TBL] [Abstract][Full Text] [Related]
43. Coexistent Isolated Tumor Cell Clusters of Infiltrating Lobular Carcinoma and Benign Glandular Inclusions of Müllerian (Endosalpingiosis) Type in an Axillary Sentinel Node: Case Report and Review of the Literature. Groth JV; Prabhu S; Wiley E Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):144-8. PubMed ID: 25203429 [TBL] [Abstract][Full Text] [Related]
44. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis. Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200 [TBL] [Abstract][Full Text] [Related]
45. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis. Piao ZH; Zhou XC; Chen JY Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661 [TBL] [Abstract][Full Text] [Related]
46. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086 [TBL] [Abstract][Full Text] [Related]
47. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract. Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742 [TBL] [Abstract][Full Text] [Related]
48. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion. Djordjevic B; Clement-Kruzel S; Atkinson NE; Malpica A Am J Surg Pathol; 2010 Oct; 34(10):1442-8. PubMed ID: 20871218 [TBL] [Abstract][Full Text] [Related]
49. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559 [TBL] [Abstract][Full Text] [Related]
50. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs. Cloutier J; Thompson ED; Cimino-Mathews A; Rooper LM; Matoso A; Argani P Hum Pathol; 2018 Dec; 82():76-86. PubMed ID: 30031098 [TBL] [Abstract][Full Text] [Related]
51. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms. Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821 [TBL] [Abstract][Full Text] [Related]
52. Endosalpingiosis and other benign epithelial inclusions in breast sentinel lymph nodes. Moreno G; Jorns JM Breast J; 2020 Feb; 26(2):274-275. PubMed ID: 31512334 [No Abstract] [Full Text] [Related]
53. Benign müllerian inclusions in pelvic and paraaortic lymph nodes. Reich O; Tamussino K; Haas J; Winter R Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810 [TBL] [Abstract][Full Text] [Related]
54. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
55. Benign mesothelial cells in mediastinal lymph nodes. Parkash V; Vidwans M; Carter D Am J Surg Pathol; 1999 Oct; 23(10):1264-9. PubMed ID: 10524528 [TBL] [Abstract][Full Text] [Related]
56. Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma. Guo W; Lee W; Lu Y; Li X; Chandan VS Hum Pathol; 2020 Dec; 106():39-44. PubMed ID: 32991930 [TBL] [Abstract][Full Text] [Related]
57. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868 [TBL] [Abstract][Full Text] [Related]
58. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Visser M; Jiwa M; Horstman A; Brink AA; Pol RP; van Diest P; Snijders PJ; Meijer CJ Int J Cancer; 2008 Jun; 122(11):2562-7. PubMed ID: 18324628 [TBL] [Abstract][Full Text] [Related]
59. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung. Berg KB; Churg A Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203 [TBL] [Abstract][Full Text] [Related]
60. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node. Piana S; Asioli S; Cavazza A Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]